| 1.1 |
7.9 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.8 |
2.3 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.6 |
2.6 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.6 |
8.3 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.6 |
1.7 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.5 |
1.5 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.5 |
1.4 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.4 |
1.2 |
GO:0060160 |
musculoskeletal movement, spinal reflex action(GO:0050883) negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.4 |
3.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.3 |
1.0 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.3 |
4.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.3 |
4.4 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
6.5 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.3 |
0.9 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.3 |
0.8 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
0.8 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.3 |
1.5 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.3 |
0.8 |
GO:0051464 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) positive regulation of cortisol secretion(GO:0051464) |
| 0.2 |
0.8 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.2 |
0.6 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.2 |
1.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.6 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.2 |
1.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
1.4 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.2 |
3.6 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
1.6 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 |
0.5 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 |
0.8 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.2 |
0.7 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.2 |
0.7 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.1 |
0.4 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.1 |
0.6 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 |
1.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
3.1 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
1.5 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
1.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
0.7 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
1.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.9 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.1 |
1.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
2.0 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
2.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.3 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
1.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 |
0.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.7 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.8 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.8 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.2 |
GO:0046881 |
sperm ejaculation(GO:0042713) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.1 |
0.6 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
1.8 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.1 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
1.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.2 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.8 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) cGMP catabolic process(GO:0046069) |
| 0.0 |
1.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
2.0 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
3.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.2 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.0 |
1.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
2.9 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
0.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.5 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
3.9 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
2.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
1.3 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.0 |
2.0 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
3.2 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.2 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.1 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.0 |
0.6 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.0 |
2.3 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.8 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.3 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.5 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
2.0 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.7 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.3 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
